Evidence map›Paper›PMID 30946638›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2019

Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.

Abhinandan Batra, Ravneet S Vohra, Steve M Chrzanowski, David W Hammers, Donovan J Lott, Krista Vandenborne, Glenn A Walter, Sean C Forbes

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01484678 recruitingnot on this mapstarted 2020, after this paper: background citation

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

TypeobservationalSponsorUniversity of FloridaRan2020 to 2026Enrolled550ConditionsDuchenne Muscular Dystrophy, Becker Muscular Dystrophy
NCT06290713 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)

TypeinterventionalSponsorUniversity of FloridaRan2024 to 2026Enrolled50ConditionsDuchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in ChildrenArmsTadalafil, Placebo, Exercise Training
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of muscle damage onNMR in biomedicine · 2022
    Article
  10. Article
  11. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  12. Article
  13. Review
  14. Mouse Fitness as Determined Through Treadmill Running and Walking.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abhinandan BatraDepartment of Physical Therapy, University of Florida , Gainesville, Florida.
Ravneet S VohraDepartment of Physical Therapy, University of Florida , Gainesville, Florida.
Steve M ChrzanowskiDepartment of Physiology and Therapeutics, University of Florida , Gainesville, Florida.
David W HammersDepartment of Pharmacology and Functional Genomics, University of Florida, Gainesville, Florida.
Donovan J LottDepartment of Physical Therapy, University of Florida , Gainesville, Florida.
Krista VandenborneDepartment of Physical Therapy, University of Florida , Gainesville, Florida.
Glenn A WalterDepartment of Physiology and Therapeutics, University of Florida , Gainesville, Florida.
Sean C ForbesDepartment of Physical Therapy, University of Florida , Gainesville, Florida.
University of Florida · US

Funding

Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
MR Assessment of Bioenergetics and Microvascular Function in Dystrophic MuscleR01AR070101 · NIAMS · UNIVERSITY OF FLORIDA · PI FORBES, SEAN C · 2016 to 2020
$1.7M
NIAMS NIH HHS R01 AR070101NIAMS NIH HHS U54 AR052646
6 · The paper itself

Abstract

Lack of sarcolemma-localized neuronal nitric oxide synthase mu (nNOSμ) contributes to muscle damage and fatigue in dystrophic muscle. In this study, we examined the effects of compensating for lack of nNOSμ with a phosphodiesterase type 5 (PDE5) inhibitor in

Indexed as

AnimalsEndurance TrainingMiceMice, Inbred C57BLMice, Inbred mdxMuscle ContractionMuscle, SkeletalMuscular Dystrophy, AnimalMuscular Dystrophy, DuchennePhosphodiesterase 5 InhibitorsPhysical Conditioning, AnimalSarcolemmaSildenafil CitratePhosphodiesterase 5 InhibitorsSildenafil CitrateDuchenne muscular dystrophyphosphodiesterase type 5 (PDE5) inhibitorsildenafil citrateskeletal muscle damage

Identifiers

PMID30946638
PMCPMC6620659
OpenAlexW2927044757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.